-
1
-
-
0002181290
-
Epidemiology of venous thromboembolism
-
Kearon C. Epidemiology of venous thromboembolism. Semin Vase Med. 2001;1(1):7-26.
-
(2001)
Semin Vase Med
, vol.1
, Issue.1
, pp. 7-26
-
-
Kearon, C.1
-
2
-
-
0037704209
-
Natural history of venous thromboembolism
-
Jun 17
-
Kearon C. Natural history of venous thromboembolism. Circulation. Jun 17 2003; 107(23 Suppl 1):122-30.
-
(2003)
Circulation
, vol.107
, Issue.23
, pp. 122-130
-
-
Kearon, C.1
-
3
-
-
0033602514
-
A comparison of three months of anticoagulation with extended anticoagulation for a first episode of idiopathic venous thromboembolism
-
Mar 25
-
Kearon C, Gent M, Hirsh J, et al. A comparison of three months of anticoagulation with extended anticoagulation for a first episode of idiopathic venous thromboembolism. N Engl J Med. Mar 25 1999; 340(12):901-907.
-
(1999)
N Engl J Med
, vol.340
, Issue.12
, pp. 901-907
-
-
Kearon, C.1
Gent, M.2
Hirsh, J.3
-
4
-
-
84874003257
-
Extended use of dabigatran, warfarin, or placebo in venous thromboembolism
-
Schulman S, Kearon C, Kakkar AK, et al. Extended use of dabigatran, warfarin, or placebo in venous thromboembolism. The New England journal of medicine. 2013;368(8):709-718.
-
(2013)
The New England Journal of Medicine
, vol.368
, Issue.8
, pp. 709-718
-
-
Schulman, S.1
Kearon, C.2
Kakkar, A.K.3
-
7
-
-
84861402643
-
Aspirin for preventing the recurrence of venous thromboembolism
-
May 24
-
Becattini C, Agnelli G, Schenone A, et al. Aspirin for preventing the recurrence of venous thromboembolism. N Engl J Med. May 24 2012;366(21):1959-1967.
-
(2012)
N Engl J Med.
, vol.366
, Issue.21
, pp. 1959-1967
-
-
Becattini, C.1
Agnelli, G.2
Schenone, A.3
-
8
-
-
84869441338
-
Low-dose aspirin for preventing recurrent venous thromboembolism
-
Nov 22
-
Brighton TA, Eikelboom JW, Mann K, et al. Low-dose aspirin for preventing recurrent venous thromboembolism. N Engl J Med. Nov 22 2012;367(21):1979-1987.
-
(2012)
N Engl J Med.
, vol.367
, Issue.21
, pp. 1979-1987
-
-
Brighton, T.A.1
Eikelboom, J.W.2
Mann, K.3
-
9
-
-
68549101842
-
The PRISMA statement for reporting systematic reviews and metaanalyses of studies that evaluate healthcare interventions: Explanation and elaboration
-
Liberati A, Altman DG, Tetzlaff J, et al. The PRISMA statement for reporting systematic reviews and metaanalyses of studies that evaluate healthcare interventions: explanation and elaboration. BMJ (Clinical research ed). 2009;339:10.
-
(2009)
BMJ (Clinical Research Ed)
, vol.339
, pp. 10
-
-
Liberati, A.1
Altman, D.G.2
Tetzlaff, J.3
-
10
-
-
84859001212
-
The Cochrane Collaborations tool for assessing risk of bias in randomised trials
-
Higgins JP, Altman DG, Gotzsche PC, et al. The Cochrane Collaborations tool for assessing risk of bias in randomised trials. BMJ. 2011;343:d5928.
-
(2011)
BMJ
, vol.343
, pp. d5928
-
-
Higgins, J.P.1
Altman, D.G.2
Gotzsche, P.C.3
-
11
-
-
23044505564
-
Definition of major bleeding in clinical investigations of antihemostatic medicinal products in non-surgical patients
-
Apr
-
Schulman S, Kearon C. Definition of major bleeding in clinical investigations of antihemostatic medicinal products in non-surgical patients. J Thromb Haemost. Apr 2005;3(4):692-694.
-
(2005)
J Thromb Haemost
, vol.3
, Issue.4
, pp. 692-694
-
-
Schulman, S.1
Kearon, C.2
-
12
-
-
0030793120
-
The results of direct and indirect treatment comparisons in meta-analysis of randomized controlled trials
-
Jun
-
Bucher HC, Guyatt GH, Griffith LE, Walter SD. The results of direct and indirect treatment comparisons in meta-analysis of randomized controlled trials. J Clin Epidemiol. Jun 1997;50(6):683-691.
-
(1997)
J Clin Epidemiol.
, vol.50
, Issue.6
, pp. 683-691
-
-
Bucher, H.C.1
Guyatt, G.H.2
Griffith, L.E.3
Walter, S.D.4
-
13
-
-
21244495516
-
Indirect comparisons of competing interventions
-
Jul, iii-iv
-
Glenny AM, Altman DG, Song F, et al. Indirect comparisons of competing interventions. Health Technol Assess. Jul 2005;9(26): 1-134, iii-iv.
-
(2005)
Health Technol Assess
, vol.9
, Issue.26
, pp. 1-134
-
-
Glenny, A.M.1
Altman, D.G.2
Song, F.3
-
14
-
-
84869838484
-
Efficacy and safety of novel oral anticoagulants for treatment of acute venous thromboembolism: Direct and adjusted indirect meta-analysis of randomised controlled trials
-
Fox BD, Kahn SR, Langleben D, Eisenberg MJ, Shimony A. Efficacy and safety of novel oral anticoagulants for treatment of acute venous thromboembolism: direct and adjusted indirect meta-analysis of randomised controlled trials. BMJ. 2012;345:e7498.
-
(2012)
BMJ
, vol.345
, pp. e7498
-
-
Fox, B.D.1
Kahn, S.R.2
Langleben, D.3
Eisenberg, M.J.4
Shimony, A.5
-
15
-
-
84872091789
-
Heart disease and stroke statistics-2013 update: A report from the American Heart Association
-
Jan 1
-
Go AS, Mozaffarian D, Roger VL, et al. Heart disease and stroke statistics-2013 update: a report from the American Heart Association. Circulation. Jan 1 2013;127(1):e6-e245.
-
(2013)
Circulation
, vol.127
, Issue.1
, pp. e6-e245
-
-
Go, A.S.1
Mozaffarian, D.2
Roger, V.L.3
-
16
-
-
77952524191
-
Systematic review: Case-fatality rates of recurrent venous thromboembolism and major bleeding events among patients treated for venous thromboembolism
-
May4
-
Carrier M, Le Gal G, Wells PS, Rodger MA. Systematic review: case-fatality rates of recurrent venous thromboembolism and major bleeding events among patients treated for venous thromboembolism. Ann Intern Med. May4 2010;152(9):578-589.
-
(2010)
Ann Intern Med
, vol.152
, Issue.9
, pp. 578-589
-
-
Carrier, M.1
Le Gal, G.2
Wells, P.S.3
Rodger, M.A.4
|